Caris Life Sciences, Inc.: Canaccord Genuity raises target price to $30 from $22
CAI•Canaccord Genuity raised its target price for Caris Life Sciences to $30 from $22.
Related News
IBM: Jefferies raises target price to $270 from $260
IBM•
Enlight Renewable Energy Ltd.: JP Morgan cuts target price to $65 from $80
ENLT•
Zealand Pharma reports ZP9830 well tolerated in Phase 1 multiple-dose trial
ZEAL•
Centuri Holdings cuts target price to $22 from $23
CTRI•
WaFd Inc: KBW cuts target price to $34 from $40
WAFD•